Pharming Group N.V. (AMS:PHARM)
Netherlands · Delayed Price · Currency is EUR 1.118
+0.033 (3.09%)
Jun 5, 2026, 5:39 PM CET
Pharming Group Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Pharming Group stock has a consensus rating of "Buy" and an average price target of €2.23. The average 1-year stock price forecast is 99.55% higher than the current stock price, while the lowest is €1.90 (+70.02%) and the highest is €2.61 (+133.56%).
Price Target: €2.23 (+99.55%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pharming Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
403.53M
from 376.13M
Increased by 7.28%
Revenue Next Year
447.80M
from 403.53M
Increased by 10.97%
EPS This Year
0.03
from 0.00
Increased by 669.25%
EPS Next Year
0.04
from 0.03
Increased by 17.68%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 412.9M | ||
| Avg | 403.5M | ||
| Low | 390.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.8% | ||
| Avg | 7.3% | ||
| Low | 3.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.03 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 669.3% | ||
| Low | - |